The firm is interested in companies that are using advances in genetic sequencing, artificial intelligence, and automation to transform the life sciences industry, with a focus on synthetic biology, medicine, and agriculture. DCVC Bio was established in 2018 and is based in San Francisco, California. Its parent company, DCVC, was founded in 2011 and invests in a range of sectors, including biotechnology. The fund is particularly interested in startups that are shaping the biochemical building blocks of the life sciences industry. For more information, visit their website, read their blog, or follow them on Twitter.